argenx CEO to present at BofA Securities 2026 Health Care Conference on May 12

argenx, a global immunology company focused on autoimmune diseases, announced that CEO Karen Massey will present at the BofA Securities 2026 Health Care Conference on May 12, 2026. The presentation will be webcast live and available for replay on the company's website. This event highlights argenx's ongoing commitment to advancing its portfolio of antibody-based medicines and its leadership in the immunology field. Investors and interested parties can access the presentation to gain insights into the company's progress and future plans.